NKGen Biotech @NKGenBiotech
NKGen Biotech (OTC:NKGN) is leveraging the power of a patient’s immune system through the development of unique natural killer (NK) cell therapies nkgenbiotech.com Santa Ana, CA Joined May 2019-
Tweets263
-
Followers313
-
Following0
-
Likes7
NKGen Biotech (OTC: NKGN) Chairman & CEO Dr. Paul Y. Song will present on troculeucel in neurodegenerative diseases at the Great Bay Cell & Gene Therapy Forum on Sept. 23 in Guangzhou, China. $NKGN Press release link: bit.ly/3T0NIMw
NKGen Biotech (OTC:NKGN) to present on troculeucel in neurodegenerative diseases at BMK 2026, highlighting troculeucel's development including clinical experience and biomarker findings. $NKGN bit.ly/4ytGzTR
NKGen Biotech (OTC: NKGN) will present at the 2026 BIOCHINA Global Forum on July 10 in Seoul. CEO Paul Y. Song, M.D., will present on troculeucel in Alzheimer’s disease and other neurodegenerative conditions. Read more: bit.ly/4wmXGG2 $NKGN
NKGen Biotech (OTC:NKGN) activates 3 new U.S. sites for Phase 2 troculeucel Alzheimer's study, expanding patient access & supporting enrollment. Learn more: bit.ly/4dkqNmI $NKGN
NKGen Biotech (OTC: NKGN) to present at the 8th Annual Neuroimmunology Drug Development Summit in Boston. CEO Dr. Paul Y. Song will highlight troculeucel’s potential in Alzheimer’s & FTD, including new mechanistic & early clinical insights. $NKGN bit.ly/4spEwgf
NKGen Biotech (OTC: NKGN) reported combined analysis of Ph 1 Alzheimer’s data at AD/PD™ 2026: 100% stable/improved, 50% improved to milder function, with dose-response, durability & GFAP biomarker support for ongoing Phase 2. $NKGN bit.ly/4bIH6HK
NKGen Biotech (OTC:NKGN) will present integrated Phase 1 analyses of troculeucel in Alzheimer’s disease at AD/PD™ 2026: oral presentation on cognitive results & poster on biomarkers (plasma GFAP). $NKGN bit.ly/46OKoHX
NKGen Biotech, Inc. (OTC: NKGN) announced Bruce L. Miller, M.D., a globally recognized dementia expert, joined its Scientific Advisory Board. His expertise in neurodegenerative disease strengthens NKGen’s clinical programs and exploration of FTD. $NKGN bit.ly/4pTjeWW
NKGen Biotech (OTC: NKGN) today provided an update on recent Board appointments and the name change of its majority-owned affiliate, NKGen Biotech Korea Co., Ltd. See press release for full details. $NKGN bit.ly/4iDJXVB
November is National #AlzheimersAwareness Month. Over 6M Americans live with Alzheimer’s. At NKGen, we’re committed to advancing science and supporting those affected. Together, we work towards a brighter future built on the hope of new therapies. #Alzheimers #nkgenbiotech
NKGen Biotech (OTC: NKGN) has received questions about how our stock is displayed on some financial platforms. This is due to data reporting limitations associated with the OTC Expert Market. We’ve issued a press release to clarify: bit.ly/46UcxMR $NKGN
NKGen Biotech [OTC:NKGN] CEO, Dr. Paul Y. Song, will present at the World Congress of Neurology 2025 in Seoul, South Korea. Dr. Song will share the scientific rationale and latest clinical findings for troculeucel in Alzheimer’s disease. $NKGN bit.ly/4nVNvEF
Update: Due to typhoon-related disruptions in the Guangzhou region, Dr. Song will not be presenting at the 3rd China Great Bay Cell and Gene Therapy Forum this Friday as originally planned. Our thoughts are with everyone affected by the storm. $NKGN
NKGen [OTC:NKGN] CEO Paul Y. Song, M.D. to present on troculeucel for neurodegenerative diseases at the 3rd China Great Bay Forum (Sept 25-26, 2025). Note: date/time changed. Updated details here: bit.ly/3IrstxY $NKGN
NKGen Biotech [OTC: NKGN] has acquired a majority stake in former parent NKMax Co., Ltd., enhancing our manufacturing, IP, and global reach in NK cell therapeutics and supporting the development of our lead Alzheimer’s therapy and pipeline expansion. $NKGN bit.ly/46bDgnF
At NKGen Biotech, we are committed to developing treatments that bring hope to those affected by Alzheimer's. Together, we work to improve the lives of patients and their families, creating a brighter future for all. #nkgenbiotech #worldalzheimersmonth #nkcelltherapy #alzheimers
NKGen Biotech [OTC:NKGN] to present “Allogeneic Enhanced NK cells without Lymphodepletion in Solid Tumors” at the Immuno-Oncology Summit 2025, held in Philadelphia, August 13th. bit.ly/3J4h2fB $NKGN
NKGen Biotech [OTC:NKGN] presented at #AAIC2025 on troculeucel’s proposed mechanism of action in Alzheimer’s disease. Data suggest troculeucel targets neuroinflammation, protein aggregation and can potentially slow disease progression. bit.ly/3INfQ02 $NKGN
On World Brain Day, we unite with global experts working diligently to improve brain health at every stage of life. #brainhealth
NKGen Biotech [OTC:NKGN] announces a poster presentation by CEO Dr. Paul Y. Song on the mechanism of action of troculeucel in patients with Alzheimer’s disease, Sunday, July 27th at the AAIC 2025 in Toronto, Canada. bit.ly/4m4Udqj $NKGN
Lex @DissidentHealth
3K Followers 1K Following Health & Nutrition Historian. Preserving hard fought lessons in a swamp of misinformation. | Politically Incorrect |
Ari Blaine @ariblaine
107 Followers 685 Following
Gleb Kulikov @gvkulikov
3 Followers 43 Following
August Long @ART7ONE
18 Followers 354 Following Independent research group analyzing global data and complex systems. Identifying risks, patterns, and insights. Open to contact.
Bat Pitt @ManniloTrader
440 Followers 701 Following 🦇batmanic tips,not medical/financial advise https://t.co/cQZk9NzQXa https://t.co/q7WMGJhlVt 💙😇🙏
Mohamad Ali Najia @MohamadNajia
304 Followers 446 Following Research Fellow @broadinstitute @BostonChildrens in @BlaineyLab + @G_Q_Daley labs • PhD @MIT_HST • hematopoiesis, immunology, chromatin, TEs, synbio, tech dev
Dr. Thomas Ichim @exosome
39K Followers 40K Following President and Chief Scientific Officer of Immorta Bio Vitalist https://t.co/fbVtWsFQw4 503 patents 4 Exits https://t.co/GHnwkq884f
Star1 @s3969211
45 Followers 29 Following
とけいそう @ysrykl
21 Followers 113 Following
George Gad @georgegad
70 Followers 192 Following Driving Brand Growth in a Digital, Yet Human World. Having fun with Crypto & AI
John Lucero, Pmhnp @jlucer53
198 Followers 881 Following I try to buy or build things for the low and sell them high 📈 Amazon Rufus Insights - Rank Higher Here https://t.co/hp6YqqAcz6
Antho @superloulout
3 Followers 2K Following
Benoit 🦇🔊 @Ben_JDC
13K Followers 4K Following co-fondateur https://t.co/hZX3tCkmvb & https://t.co/YwqL2qywXK, fellow @nodeguardians, membre https://t.co/11dqoAPFxb
GroovyMG @groovygrahams
153 Followers 833 Following
KIM TAEYOUNG @KimDalguji
1 Followers 8 Following
Danny Sullivan @mrdannysullivan
607 Followers 2K Following Contributing Editor at @LongevityTech. Writer, marketer, PR'er, traveller, reader, runner, technolover and lots of other ers...
Shawn Tennie @TennieShaw9411
15 Followers 16 Following
Chris Reagan @Chrismreagan
26 Followers 301 Following
Palmer Johnson @calgrad74
34 Followers 915 Following
Title21 Health Soluti... @Title21HS
50 Followers 431 Following Delivering innovative, integrated tech for healthcare & life sciences since 2001. Driving compliance, efficiency & quality to enhance patient safety & care.
쿠키닷넷 @jamproject2014
35 Followers 206 Following
Rob Claar @robclaar
155 Followers 624 Following Rob writes about harmonization of personal & professional values, healthcare innovation & Japan business & culture
Badbunny ᥫᩣ @BADBUNNY951
861 Followers 1K Following Vegas躲过子弹； SF被砸过车； LA惊魂墨区； 东京银座闹过分手； 札幌市政广场滑过雪； 涵馆爱上海胆盖饭； 大阪生啃帝王蟹； 首尔混进游行队伍； 清迈吃过斋饭； 曼谷做过抓龙筋； 芭提雅喝过假酒； 普吉过过满月节； 奥克兰捞过大黑鲍； 墨尔本赌场蹭过饭； Dubai哈利法塔顶唱过征服； 阿布扎比清真寺搭过讪
Ken Thomas @betemorfold
48 Followers 350 Following
Michael LoPresti (Gin... @GineProGo
17 Followers 98 Following Specialist in evidence generation and market access for medtech and regenerative medicines in Japan
David Schneider-Josep... @TheDavidSJ
1K Followers 4K Following Working on AI gov. Past: Technology and Security Policy @ RAND re: AI compute, telemetry database lead & 1st stage landing software @ SpaceX; AWS; Google.
Nkap80 @Cricket99238
514 Followers 5K Following A proud Dad. A passionate biotech researcher. A sports fanatic. A PhD and a foolish investor with a huge appetite to learn and explore 👍🍺🦠🧬!!
simster1 @simster1
439 Followers 2K Following
owen @owenjoban
0 Followers 90 Following
🍁 @Ahmed_0xu
426 Followers 2K Following
Pam🇮🇳 @Bio98126
11 Followers 397 Following
2.0 @mhl2dot0
2 Followers 16 Following
Julian Hoffmann @JulianHoff11653
2 Followers 17 Following
Waggoner Lab @LabWaggoner
13K Followers 8K Following Research lab of Dr. Stephen Waggoner. Opinions expressed are Dr. Waggoner's alone and not on behalf of lab staff or employer. @labwaggoner.bsky.social
Khaled @kaled_faraj
242 Followers 2K Following أعلل النفسَ بالآمال ارقبها، ما أضيق العيشَ لولا فسحة الأَملِ .
Bobby Gelacio @HoKitty30
7 Followers 57 Following
Michael Hall @mphmd711
30 Followers 117 Following
Chelli Miller @cmiller1225
6K Followers 7K Following Trailblazing Biotech and Medtech Marketing Exec | Investor Education| Biotech Events and Social Expert | VP Customer Success and Partner at Content Carnivores
Teach Connect @Teach_Connect
371 Followers 916 Following Supporting educators.ikkkmiand schools thrive | Building Professional Learning Communities.
PRISM Digital Media @PrismDM
2K Followers 1K Following Prism Digital Media provides digital media, content creation and public relations solutions for emerging brands.
DUST @gamananara1
74 Followers 392 Following
jubilancy.ai @Radzikowski
674 Followers 2K Following Founder & CEO, https://t.co/k9pzpcW2U2 | The #1 AI mirror for self-reflection, memory, and human connection.You might like
